[MO15] Mini-Oral Session 15　Translational Research / Clinical Pharmacology 1（Precision Medicine）
【E】

[MO15-1] Assessment for the treatment lines at comprehensive genomic profiling tests in patients with advanced solid cancers

^○Kanako Hagio¹, Junko Kikuchi¹, Kohichi Takada², Hiroki Tanabe³, Minako Sugiyama^1,4, Yoshihito Ohhara^1,5, Toraji Amano^1,5, Satoshi Yuki⁶, Yoshito Komatsu⁷, Yutaka Hatanaka⁸, Ichiro Yabe⁹, Yoshihiro Matsuno¹⁰, Atsushi Manabe⁴, Akihiro Sakurai¹¹, Atsushi Ishiguro¹², Masato Takahashi¹³, Hirohito Naruse¹⁴, Yusuke Mizukami³, Hirotoshi Dosaka-Akita^1,5, Ichiro Kinoshita^1,5 (1.Division of Clinical Cancer Genomics, Hokkaido University Hospital, 2.Department of Medical Oncology, Sapporo Medical University School of Medicine, 3.Genetic Oncology Department, Asahikawa Medical University Hospital, 4.Department of Pediatrics, Hokkaido University Hospital, 5.Department of Medical Oncology, Hokkaido University Hospital, 6.Department of Gastroenterology and Hepatology, Hokkaido University Hospital, 7.Department of Cancer Chemotherapy, Hokkaido University Hospital Cancer Center, 8.Center for Development of Advanced Diagnostics, Hokkaido University Hospital, 9.Division of Clinical Genetics, Hokkaido University Hospital, 10.Department of Surgical Pathology, Hokkaido University Hospital, 11.Department of Medical Genetics and Genomics, Sapporo Medical University, 12.Department of Medical Oncology, Teine Keijinkai Hospital, 13.Department of Cancer Genome Medical Center, NHO Hokkaido Cancer Center, 14.Department of Gastroenterology, Hakodate Municipal Hospital)